UroGen Pharma announces offering of ordinary shares, warrants

UroGen Pharma Ltd. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants. All of the ordinary shares and pre-funded warrants to be sold in the proposed offering will be offered by UroGen. TD Cowen and Guggenheim Securities are acting as joint book-running managers for the proposed offering. Oppenheimer & Co. is acting as lead manager for the proposed offering. Ladenburg Thalmann is acting as co-manager for the proposed offering.